Tirzepatide

Identity & Classification

Class

Dual incretin receptor agonist

CAS

2023788-19-2

Research category

Metabolic Research

Range

New / Branded

Risk tier

Tier A

Full identity reference: Dual incretin receptor agonist. The active is an approved prescription drug substance; supply RUO only. CAS 2023788-19-2 (confirm from COA).

Mechanism Studied in Research

Co-agonism of GLP-1R and GIPR; used as a reference standard in incretin and insulin-signalling research.

Research Interest Areas

Incretin pharmacology, glucose-handling models, receptor binding assays.

Specifications

Form

Lyophilised solid

Kit total

20mg

Vial config

10mg x 2

QC

HPLC / MS Certificate of Analysis

Lead time

Confirmed at quote

Supply basis

Research use only · institution-verified

Source: 20mg kit, 10mg/vial x 2, lyophilised. Purity by HPLC/MS COA.

Storage & Handling

Reference material is supplied lyophilised in sealed vials. Recommended laboratory handling: store sealed vials at -20°C protected from light and moisture. Once reconstituted in a research-grade aqueous buffer, hold at 2–8°C for short-term use or aliquot and store at -20°C or below to limit freeze-thaw cycles. Allow vials to equilibrate to room temperature before opening to prevent condensation.

Reconstitution buffer, concentration, and assay format are determined by the receiving laboratory’s protocol. Syther Peptides does not supply usage protocols.

Quality & Compliance

Certificate of Analysis

Purity and identity are confirmed by Certificate of Analysis (HPLC / MS), available on request alongside the quote. The COA documents batch number, identity confirmation method, purity by HPLC peak-area, and reference to the analytical method used.

How to Enquire

1. STEP / 01
   Submit enquiry

   Provide institution, intended laboratory application, compound, quantity and format.

2. STEP / 02
   Research-gate check

   We confirm research-organisation context. Enquiries that cannot evidence one are declined.

3. STEP / 03
   Quote & COA

   Availability, lead time, and Certificate of Analysis returned within one business day.

FAQ

What is Tirzepatide?

Tirzepatide is a dual GLP-1 / GIP receptor agonist peptide used as a laboratory reference compound in metabolic and incretin-signalling research. It is supplied for research use only and not for human consumption.

What class of peptide is Tirzepatide?

Tirzepatide is described as: Dual incretin receptor agonist.

What pathway or receptor does Tirzepatide act on?

Co-agonism of GLP-1R and GIPR; used as a reference standard in incretin and insulin-signalling research.

What is Tirzepatide studied for in research?

Research interest areas include: Incretin pharmacology, glucose-handling models, receptor binding assays.

Is Tirzepatide for human use?

No. Tirzepatide is supplied for laboratory research use only and is not for human or veterinary consumption.

How is identity and purity of Tirzepatide confirmed?

Identity and purity are confirmed by HPLC/MS Certificate of Analysis, supplied on request. Every vial carries a scratch-code that can be verified on this site.